Compare Globus Medical Inc. Class A Common Stock (GMED) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Consumer Staples Select Sector SPDR Fund — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Consumer Staples Select Sector SPDR Fund trades at $87.42 (market cap $14.73B). The key difference: Consumer Staples Select Sector SPDR Fund is the larger of the two by market cap, and Consumer Staples Select Sector SPDR Fund is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Consumer Staples Select Sector SPDR Fund for 73 Days on average.
| GMED | XLP | |
|---|---|---|
Market Cap | $10.25B | $14.73B |
Volume | 1,059,528 | 14,288,954 |
Sector | Health | — |
52-Week High | $96.82 | $90.00 |
52-Week Low | $58.33 | $75.61 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $9.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
XLP trades at $84.19, down 0.26% on the day, with strong technical momentum showing a bullish moving average signal despite an overbought RSI reading. The ETF maintains 100% analyst buy ratings and recently announced a $0.54 dividend payable in September 2026. Consumer staples sector performance has been resilient, with XLP gaining 6.6% year-to-date while outperforming discretionary counterparts by over 13 percentage points.
The defensive nature of consumer staples provides stability amid market volatility, though elevated interest rates pose a headwind. With strong technical momentum and unanimous analyst support, XLP offers defensive exposure with dividend income potential, but investors should monitor inflation pressures and consumer spending trends that could impact sector performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
